Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,066 across all filing types
Latest filing 2008-10-14 AGM Information
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 95% confidence The document is titled 'NOTICE OF ANNUAL GENERAL MEETING' and details the agenda for the AGM of Uni-Bio Science Group Limited, including items such as approval of audited financial statements, re-election of directors, re-appointment of auditors, and approval of share allotment and purchase mandates. It is a notice announcing the meeting and the business to be transacted, not the actual meeting materials or minutes. The document is about the AGM event and the resolutions to be considered, which fits the category of AGM Information (AGM-R). The document length is sufficient and contains detailed agenda items typical for an AGM notice. Therefore, the classification is AGM-R with high confidence.
2008-10-14 English
PROXY FORM
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a proxy form for use by shareholders at the annual general meeting (AGM) of Uni-Bio Science Group Limited. It includes instructions for appointing a proxy to vote on resolutions such as approval of audited financial statements, re-election of directors, appointment of auditors, and share allotment and repurchase mandates. This type of document is typically distributed to shareholders to facilitate voting at the AGM and is not the AGM presentation materials themselves, nor the voting results. It is a solicitation for proxy votes, which fits the definition of Proxy Solicitation & Information Statement (PSI). The document length is about 4811 characters, consistent with a detailed proxy form. Therefore, the correct classification is PSI with high confidence.
2008-10-14 English
GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, PROPOSED RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 95% confidence The document is a circular from Uni-Bio Science Group Limited dated 15 October 2008. It includes detailed information about the upcoming Annual General Meeting (AGM) scheduled for 6 November 2008, including the notice of the meeting, proposed resolutions such as general mandates to issue and repurchase shares, and the proposed re-election of directors. The document contains a letter from the board, explanatory statements, and appendices related to the AGM. It is not a full annual report or financial statement but rather a comprehensive circular providing information and notice for the AGM. This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during the AGM. The document is lengthy (15,000 characters) and contains substantive content related to the AGM, not just a brief announcement or proxy solicitation. Therefore, the correct classification is AGM Information (AGM-R).
2008-10-14 English
Annual Report 2008
Annual Report Classification · 100% confidence The document is titled 'Annual Report' and contains detailed sections typical of a full annual report, including Chairman's Statement, Management Discussion and Analysis, Directors' Profile, Corporate Governance Report, Directors' Report, Independent Auditor's Report, and comprehensive financial statements such as Consolidated Income Statement, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement, and Notes to the Financial Statements. The content includes detailed financial performance data for the fiscal year ended 31 March 2008, business reviews, acquisitions, disposals, and future outlook. The length of the document (15,000 characters) and the depth of information confirm it is the full annual report rather than an announcement or summary. Therefore, the appropriate classification is Annual Report (10-K). FY 2008
2008-10-14 English
UNUSUAL PRICE AND TURNOVER MOVEMENTS
Regulatory Filings Classification · 95% confidence The document is a short announcement made at the request of The Stock Exchange of Hong Kong Limited regarding unusual price and turnover movements of the company's shares. It states that the directors are not aware of any reasons for the increase in price and volume and confirms no negotiations or agreements related to acquisitions or realizations. The document references a previous announcement of annual results but does not contain any financial data or detailed report content itself. The length is only 1802 characters, which is quite short and fits the pattern of a regulatory announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2008-10-03 English
UNUSUAL PRICE AND TURNOVER MOVEMENTS
Regulatory Filings Classification · 95% confidence The document is a short announcement made at the request of the Stock Exchange of Hong Kong Limited regarding unusual price and turnover movements of the company's shares. It states that the directors are not aware of any reasons for the increase in price and volume and confirms no negotiations or agreements related to acquisitions or realizations. The document references a previous announcement of annual results but does not contain any financial data or detailed report. The length is only 1802 characters, indicating it is a brief announcement rather than a full report. It fits the category of a Regulatory Filing (RNS) as it is a compliance-related announcement responding to exchange requirements and does not contain substantive financial or management information.
2008-10-03 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.